DuoGenic StemCells corporation (7607.TWO)
TWD 24.2
(1.68%)
TWD 24.2
(1.68%)
| Breakdown | 2023 | 2022 | 2021 |
|---|---|---|---|
| Operating Cash Flow | -43.82 Million | -33.42 Million | -20.03 Million |
| Net Income | -45.23 Million | -34.05 Million | -21.98 Million |
| Depreciation & Amortization | 7.01 Million | 5.33 Million | 2.66 Million |
| Deferred income taxes | - | - | - |
| Stock-based compensation | - | - | - |
| Change in working capital | -4.53 Million | -4.3 Million | -2.98 Million |
| Other non-cash items | 18.78 Million | 14.96 Million | 9.86 Million |
| Investing Cash Flow | -1 Million | -12.04 Million | -9 Million |
| Investments in PPE | -1 Million | -12.04 Million | -9 Million |
| Acquisitions | - | - | - |
| Investment purchases | - | - | - |
| Sales/Maturities of investments | - | - | - |
| Other Investing Activities | -39 Thousand | - | - |
| Financing Cash Flow | 48.3 Million | 36.86 Million | 62.42 Million |
| Debt repayment | - | - | - |
| Dividends payments | - | - | - |
| Common Stock Repurchased | - | - | - |
| Common Stock Issuance | 50.04 Million | 37.99 Million | 63.26 Million |
| Other Financing Activities | -1.89 Million | - | - |
| Accounts receivables | -823 Thousand | -2.37 Million | 63 Thousand |
| Accounts payables | -110 Thousand | 119 Thousand | -206 Thousand |
| Inventory | -4.88 Million | -2.44 Million | -2.12 Million |
| Other working capital | 1.29 Million | 394 Thousand | -713 Thousand |
| Cash at beginning of period | 42.8 Million | 51.41 Million | 18.03 Million |
| Cash at end of period | 46.29 Million | 42.8 Million | 51.41 Million |
| Capital Expenditure | -1 Million | -12.04 Million | -9 Million |
| Effect of forex changes on cash | - | - | - |
| Net cash flow / Change in cash | 3.48 Million | -8.6 Million | 33.38 Million |
| Free Cash Flow | -44.82 Million | -45.46 Million | -29.04 Million |
| Breakdown | 2024 Q2 | 2023 FY | 2023 Q4 | 2023 Q2 | 2022 Q4 | 2022 FY |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -32.29 Million | -45.23 Million | -23.26 Million | -21.96 Million | -19.59 Million | -34.05 Million |
| Depreciation & Amortization | 3.64 Million | 7.01 Million | 3.58 Million | 3.42 Million | 3.11 Million | 5.33 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | 2.53 Million | -4.53 Million | -390 Thousand | -4.14 Million | -1.4 Million | -4.3 Million |
| Other non-cash items | 3.41 Million | 18.78 Million | 7.97 Million | 10.8 Million | 9.44 Million | 14.96 Million |
| Investing Cash Flow | -114 Thousand | -1 Million | -515 Thousand | -486 Thousand | -3.94 Million | -12.04 Million |
| Investments in PPE | -114 Thousand | -1 Million | -515 Thousand | -486 Thousand | -3.94 Million | -12.04 Million |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | - | - | - | - |
| Financing Cash Flow | -1.04 Million | 48.3 Million | -955 Thousand | 49.26 Million | 1.33 Million | 36.86 Million |
| Debt repayment | - | - | - | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | 50.04 Million | - | 50.04 Million | 2 Million | 37.99 Million |
| Other Financing Activities | -1.04 Million | - | - | - | - | - |
| Accounts receivables | 466 Thousand | -823 Thousand | 2.2 Million | -3.02 Million | -886 Thousand | -2.37 Million |
| Accounts payables | 10 Thousand | -110 Thousand | -85 Thousand | -25 Thousand | -175 Thousand | 119 Thousand |
| Inventory | 4.7 Million | -4.88 Million | -4.36 Million | -529 Thousand | -2.48 Million | -2.44 Million |
| Other working capital | -2.65 Million | 1.29 Million | 1.84 Million | -559 Thousand | 2.13 Million | 394 Thousand |
| Cash at beginning of period | 46.29 Million | 42.8 Million | 69.27 Million | 42.8 Million | 63.64 Million | 51.41 Million |
| Cash at end of period | 20.31 Million | 46.29 Million | 46.29 Million | 69.27 Million | 42.8 Million | 42.8 Million |
| Capital Expenditure | -114 Thousand | -1 Million | -515 Thousand | -486 Thousand | -3.94 Million | -12.04 Million |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | -25.98 Million | 3.48 Million | -22.97 Million | 26.46 Million | -20.83 Million | -8.6 Million |
| Free Cash Flow | -24.93 Million | -44.82 Million | -22.02 Million | -22.79 Million | -22.16 Million | -45.46 Million |
MC
GRAT
SVT
UGP
MSP
6794